Close Menu

UK Centre for Medical Research and Innovation

The consortium, which spans more than a dozen UK cities, will sequence patient samples to understand the spread and evolution of the novel coronavirus.

The multi-partner institute in London will take on the name of one of the UK's most famous biologists.

The new partners will each contribute £40 million in the UK Centre for Medical Research and Innovation, bringing the total committed funding for the planned London institute to £700 million ($1.14 billion).

UKCMRI has said genomics and other technologies will be applied toward its four key goals: research excellence, supporting the UK's biomedical research effort, recruiting and training researchers, and fostering translation of discoveries into new treatments against disease.

Britain's Conservative party government plans to leave science funding flat for four years while it hacks away at other government expenses in order to bring down its deficits.

The application is expected to be heard before the end of the year by members of the Camden Council's Development Control Committee, following a formal consultation by the council. If approved, construction will begin next year, with completion set for 2015.

Sir Paul Nurse, a Nobel laureate and the president of New York's Rockefeller University since 2003, will oversee The UK Centre for Medical Research and Innovation's.

The UK Centre for Medical Research and Innovation will maintain "a strong focus" on cancer, heart disease, and stroke as well as disorders of the immune system and later-life diseases of the nervous system, partners in the planned £600 million institute said.

The coalition headed by David Cameron's Conservative Party said that it remains committed to the project, promising to spend the remaining £233 million set aside for UKCMRI by the UK government in phases over the next five years.

An advertisement posted this week in Nature seeks candidates for the position who "must be internationally renowned biomedical scientists capable of leading a complex research organisation."

Pages

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.

Researchers in France are developing a new, fast test for SARS-CoV-2 that initial testing indicates may be highly accurate, the Guardian says.

In Cell this week: analysis of fitness patterns among SARS-CoV-2 isolates, single-cell transcriptome analysis of immune features in COVID-19, and more.